Interaction between metabotropic and NMDA glutamate receptors in the periaqueductal grey pain modulatory system

The formalin test was used to investigate the interactive role of periaqueductal grey (PAG) N-methyl-D-aspartate (NMDA) and metabotropic glutamate (mGlu) receptors in the modulation of persistent noxious stimulation in mice. Intra-PAG microinjections of 1 or 3 nmol NMDA, a selective agonist at NMDA-...

Full description

Saved in:
Bibliographic Details
Published in:Naunyn-Schmiedeberg's archives of pharmacology 2001-11, Vol.364 (5), p.437-443
Main Authors: Berrino, L, Oliva, P, Rossi, F, Palazzo, E, Nobili, B, Maione, S
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c289t-37c0edffe4ad0c0c26985e325941e793de368164b76362de5da98b15760c0d273
cites
container_end_page 443
container_issue 5
container_start_page 437
container_title Naunyn-Schmiedeberg's archives of pharmacology
container_volume 364
creator Berrino, L
Oliva, P
Rossi, F
Palazzo, E
Nobili, B
Maione, S
description The formalin test was used to investigate the interactive role of periaqueductal grey (PAG) N-methyl-D-aspartate (NMDA) and metabotropic glutamate (mGlu) receptors in the modulation of persistent noxious stimulation in mice. Intra-PAG microinjections of 1 or 3 nmol NMDA, a selective agonist at NMDA-subtype receptors, decreased the nociceptive response (-94+/-5% with 3 nmol) during the latter phase of the test. This effect was antagonized by MK-801, a selective antagonist at NMDA receptors. No change in the early nociceptive phase was observed after NMDA injection. Pretreatment either with 2-methyl-6-phenylethynylpyridine (MPEP, 25 nmol/mouse), a selective antagonist at mGlu5 receptors, or with (2S)-alpha-ethylglutamic acid [(2S)-alpha-EGlu, 30 nmol/mouse], a selective antagonist at group-II mGluRs, prevented the NMDA-induced antinociceptive effect during the late hyperalgesic phase. Pretreatment with (R,S)-alpha-methylserine-O-phosphate [(R,S)-alpha-MSOP, 70 nmol/mouse], a selective antagonist at group-III mGlu receptors, had no effect on the NMDA-induced antinociception. None of the antagonists changed the formalin-induced nociceptive behaviour per se with the dosages used in combination with NMDA. MPEP at 50 nmol/mouse, however, potentiated the early nociceptive phase whilst 100 nmol/mouse attenuated the late phase. Similarly, at the higher dose of 140 nmol/mouse, (R,S)-alpha-MSOP decreased the late hyperalgesic phase. These results provide additional evidence that NMDA and mGlu receptors participate in modulating the hyperalgesia induced by peripheral noxious stimulation. In particular, mGlu receptors may modulate the NMDA receptors in the PAG since their physiological stimulation seems to be required for the NMDA-induced effect. This suggests that, together with ionotropic glutamate receptors, mGlu receptors also play a role in modulating a type of spinal cord neuroplasticity (i.e. wind-up) that has been proposed to mediate hyperalgesia.
doi_str_mv 10.1007/s002100100477
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_s002100100477</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11692227</sourcerecordid><originalsourceid>FETCH-LOGICAL-c289t-37c0edffe4ad0c0c26985e325941e793de368164b76362de5da98b15760c0d273</originalsourceid><addsrcrecordid>eNpVkEtLxDAUhYMozji6dCv5A9U82qRZDuMTRt3ouqTJ7Vhpm5qkSP-9kRkQ4cK5cD7O4kPokpJrSoi8CYSw9KTLpTxCS5pzllFF2TFapqrMKFPlAp2F8EkIEbQoTtGCUqEYY3KJ3NMQwWsTWzfgGuI3wIB7iLp20buxNVgPFr88367xrpui7nUE7MHAGJ0PuB1w_AA8gm_11wR2MlF3eOdhxqNOZe_s1OmEzjjMIUJ_jk4a3QW4OOQKvd_fvW0es-3rw9Nmvc0MK1XMuDQEbNNAri0xxDChygI4K1ROQSpugYuSiryWggtmobBalTUtpEi0ZZKvULbfNd6F4KGpRt_22s8VJdWvuOqfuMRf7flxqnuwf_TBFP8Bs5ZqSA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Interaction between metabotropic and NMDA glutamate receptors in the periaqueductal grey pain modulatory system</title><source>Springer Link</source><creator>Berrino, L ; Oliva, P ; Rossi, F ; Palazzo, E ; Nobili, B ; Maione, S</creator><creatorcontrib>Berrino, L ; Oliva, P ; Rossi, F ; Palazzo, E ; Nobili, B ; Maione, S</creatorcontrib><description>The formalin test was used to investigate the interactive role of periaqueductal grey (PAG) N-methyl-D-aspartate (NMDA) and metabotropic glutamate (mGlu) receptors in the modulation of persistent noxious stimulation in mice. Intra-PAG microinjections of 1 or 3 nmol NMDA, a selective agonist at NMDA-subtype receptors, decreased the nociceptive response (-94+/-5% with 3 nmol) during the latter phase of the test. This effect was antagonized by MK-801, a selective antagonist at NMDA receptors. No change in the early nociceptive phase was observed after NMDA injection. Pretreatment either with 2-methyl-6-phenylethynylpyridine (MPEP, 25 nmol/mouse), a selective antagonist at mGlu5 receptors, or with (2S)-alpha-ethylglutamic acid [(2S)-alpha-EGlu, 30 nmol/mouse], a selective antagonist at group-II mGluRs, prevented the NMDA-induced antinociceptive effect during the late hyperalgesic phase. Pretreatment with (R,S)-alpha-methylserine-O-phosphate [(R,S)-alpha-MSOP, 70 nmol/mouse], a selective antagonist at group-III mGlu receptors, had no effect on the NMDA-induced antinociception. None of the antagonists changed the formalin-induced nociceptive behaviour per se with the dosages used in combination with NMDA. MPEP at 50 nmol/mouse, however, potentiated the early nociceptive phase whilst 100 nmol/mouse attenuated the late phase. Similarly, at the higher dose of 140 nmol/mouse, (R,S)-alpha-MSOP decreased the late hyperalgesic phase. These results provide additional evidence that NMDA and mGlu receptors participate in modulating the hyperalgesia induced by peripheral noxious stimulation. In particular, mGlu receptors may modulate the NMDA receptors in the PAG since their physiological stimulation seems to be required for the NMDA-induced effect. This suggests that, together with ionotropic glutamate receptors, mGlu receptors also play a role in modulating a type of spinal cord neuroplasticity (i.e. wind-up) that has been proposed to mediate hyperalgesia.</description><identifier>ISSN: 0028-1298</identifier><identifier>EISSN: 1432-1912</identifier><identifier>DOI: 10.1007/s002100100477</identifier><identifier>PMID: 11692227</identifier><language>eng</language><publisher>Germany</publisher><subject>Animals ; Dizocilpine Maleate - pharmacology ; Drug Interactions ; Excitatory Amino Acid Antagonists - pharmacology ; Male ; Mice ; N-Methylaspartate - pharmacology ; Pain Measurement ; Periaqueductal Gray - drug effects ; Pyridines - pharmacology ; Receptors, Metabotropic Glutamate - drug effects ; Receptors, N-Methyl-D-Aspartate - drug effects</subject><ispartof>Naunyn-Schmiedeberg's archives of pharmacology, 2001-11, Vol.364 (5), p.437-443</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c289t-37c0edffe4ad0c0c26985e325941e793de368164b76362de5da98b15760c0d273</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11692227$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berrino, L</creatorcontrib><creatorcontrib>Oliva, P</creatorcontrib><creatorcontrib>Rossi, F</creatorcontrib><creatorcontrib>Palazzo, E</creatorcontrib><creatorcontrib>Nobili, B</creatorcontrib><creatorcontrib>Maione, S</creatorcontrib><title>Interaction between metabotropic and NMDA glutamate receptors in the periaqueductal grey pain modulatory system</title><title>Naunyn-Schmiedeberg's archives of pharmacology</title><addtitle>Naunyn Schmiedebergs Arch Pharmacol</addtitle><description>The formalin test was used to investigate the interactive role of periaqueductal grey (PAG) N-methyl-D-aspartate (NMDA) and metabotropic glutamate (mGlu) receptors in the modulation of persistent noxious stimulation in mice. Intra-PAG microinjections of 1 or 3 nmol NMDA, a selective agonist at NMDA-subtype receptors, decreased the nociceptive response (-94+/-5% with 3 nmol) during the latter phase of the test. This effect was antagonized by MK-801, a selective antagonist at NMDA receptors. No change in the early nociceptive phase was observed after NMDA injection. Pretreatment either with 2-methyl-6-phenylethynylpyridine (MPEP, 25 nmol/mouse), a selective antagonist at mGlu5 receptors, or with (2S)-alpha-ethylglutamic acid [(2S)-alpha-EGlu, 30 nmol/mouse], a selective antagonist at group-II mGluRs, prevented the NMDA-induced antinociceptive effect during the late hyperalgesic phase. Pretreatment with (R,S)-alpha-methylserine-O-phosphate [(R,S)-alpha-MSOP, 70 nmol/mouse], a selective antagonist at group-III mGlu receptors, had no effect on the NMDA-induced antinociception. None of the antagonists changed the formalin-induced nociceptive behaviour per se with the dosages used in combination with NMDA. MPEP at 50 nmol/mouse, however, potentiated the early nociceptive phase whilst 100 nmol/mouse attenuated the late phase. Similarly, at the higher dose of 140 nmol/mouse, (R,S)-alpha-MSOP decreased the late hyperalgesic phase. These results provide additional evidence that NMDA and mGlu receptors participate in modulating the hyperalgesia induced by peripheral noxious stimulation. In particular, mGlu receptors may modulate the NMDA receptors in the PAG since their physiological stimulation seems to be required for the NMDA-induced effect. This suggests that, together with ionotropic glutamate receptors, mGlu receptors also play a role in modulating a type of spinal cord neuroplasticity (i.e. wind-up) that has been proposed to mediate hyperalgesia.</description><subject>Animals</subject><subject>Dizocilpine Maleate - pharmacology</subject><subject>Drug Interactions</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Male</subject><subject>Mice</subject><subject>N-Methylaspartate - pharmacology</subject><subject>Pain Measurement</subject><subject>Periaqueductal Gray - drug effects</subject><subject>Pyridines - pharmacology</subject><subject>Receptors, Metabotropic Glutamate - drug effects</subject><subject>Receptors, N-Methyl-D-Aspartate - drug effects</subject><issn>0028-1298</issn><issn>1432-1912</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpVkEtLxDAUhYMozji6dCv5A9U82qRZDuMTRt3ouqTJ7Vhpm5qkSP-9kRkQ4cK5cD7O4kPokpJrSoi8CYSw9KTLpTxCS5pzllFF2TFapqrMKFPlAp2F8EkIEbQoTtGCUqEYY3KJ3NMQwWsTWzfgGuI3wIB7iLp20buxNVgPFr88367xrpui7nUE7MHAGJ0PuB1w_AA8gm_11wR2MlF3eOdhxqNOZe_s1OmEzjjMIUJ_jk4a3QW4OOQKvd_fvW0es-3rw9Nmvc0MK1XMuDQEbNNAri0xxDChygI4K1ROQSpugYuSiryWggtmobBalTUtpEi0ZZKvULbfNd6F4KGpRt_22s8VJdWvuOqfuMRf7flxqnuwf_TBFP8Bs5ZqSA</recordid><startdate>20011101</startdate><enddate>20011101</enddate><creator>Berrino, L</creator><creator>Oliva, P</creator><creator>Rossi, F</creator><creator>Palazzo, E</creator><creator>Nobili, B</creator><creator>Maione, S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20011101</creationdate><title>Interaction between metabotropic and NMDA glutamate receptors in the periaqueductal grey pain modulatory system</title><author>Berrino, L ; Oliva, P ; Rossi, F ; Palazzo, E ; Nobili, B ; Maione, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c289t-37c0edffe4ad0c0c26985e325941e793de368164b76362de5da98b15760c0d273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Animals</topic><topic>Dizocilpine Maleate - pharmacology</topic><topic>Drug Interactions</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Male</topic><topic>Mice</topic><topic>N-Methylaspartate - pharmacology</topic><topic>Pain Measurement</topic><topic>Periaqueductal Gray - drug effects</topic><topic>Pyridines - pharmacology</topic><topic>Receptors, Metabotropic Glutamate - drug effects</topic><topic>Receptors, N-Methyl-D-Aspartate - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berrino, L</creatorcontrib><creatorcontrib>Oliva, P</creatorcontrib><creatorcontrib>Rossi, F</creatorcontrib><creatorcontrib>Palazzo, E</creatorcontrib><creatorcontrib>Nobili, B</creatorcontrib><creatorcontrib>Maione, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Naunyn-Schmiedeberg's archives of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berrino, L</au><au>Oliva, P</au><au>Rossi, F</au><au>Palazzo, E</au><au>Nobili, B</au><au>Maione, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interaction between metabotropic and NMDA glutamate receptors in the periaqueductal grey pain modulatory system</atitle><jtitle>Naunyn-Schmiedeberg's archives of pharmacology</jtitle><addtitle>Naunyn Schmiedebergs Arch Pharmacol</addtitle><date>2001-11-01</date><risdate>2001</risdate><volume>364</volume><issue>5</issue><spage>437</spage><epage>443</epage><pages>437-443</pages><issn>0028-1298</issn><eissn>1432-1912</eissn><abstract>The formalin test was used to investigate the interactive role of periaqueductal grey (PAG) N-methyl-D-aspartate (NMDA) and metabotropic glutamate (mGlu) receptors in the modulation of persistent noxious stimulation in mice. Intra-PAG microinjections of 1 or 3 nmol NMDA, a selective agonist at NMDA-subtype receptors, decreased the nociceptive response (-94+/-5% with 3 nmol) during the latter phase of the test. This effect was antagonized by MK-801, a selective antagonist at NMDA receptors. No change in the early nociceptive phase was observed after NMDA injection. Pretreatment either with 2-methyl-6-phenylethynylpyridine (MPEP, 25 nmol/mouse), a selective antagonist at mGlu5 receptors, or with (2S)-alpha-ethylglutamic acid [(2S)-alpha-EGlu, 30 nmol/mouse], a selective antagonist at group-II mGluRs, prevented the NMDA-induced antinociceptive effect during the late hyperalgesic phase. Pretreatment with (R,S)-alpha-methylserine-O-phosphate [(R,S)-alpha-MSOP, 70 nmol/mouse], a selective antagonist at group-III mGlu receptors, had no effect on the NMDA-induced antinociception. None of the antagonists changed the formalin-induced nociceptive behaviour per se with the dosages used in combination with NMDA. MPEP at 50 nmol/mouse, however, potentiated the early nociceptive phase whilst 100 nmol/mouse attenuated the late phase. Similarly, at the higher dose of 140 nmol/mouse, (R,S)-alpha-MSOP decreased the late hyperalgesic phase. These results provide additional evidence that NMDA and mGlu receptors participate in modulating the hyperalgesia induced by peripheral noxious stimulation. In particular, mGlu receptors may modulate the NMDA receptors in the PAG since their physiological stimulation seems to be required for the NMDA-induced effect. This suggests that, together with ionotropic glutamate receptors, mGlu receptors also play a role in modulating a type of spinal cord neuroplasticity (i.e. wind-up) that has been proposed to mediate hyperalgesia.</abstract><cop>Germany</cop><pmid>11692227</pmid><doi>10.1007/s002100100477</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-1298
ispartof Naunyn-Schmiedeberg's archives of pharmacology, 2001-11, Vol.364 (5), p.437-443
issn 0028-1298
1432-1912
language eng
recordid cdi_crossref_primary_10_1007_s002100100477
source Springer Link
subjects Animals
Dizocilpine Maleate - pharmacology
Drug Interactions
Excitatory Amino Acid Antagonists - pharmacology
Male
Mice
N-Methylaspartate - pharmacology
Pain Measurement
Periaqueductal Gray - drug effects
Pyridines - pharmacology
Receptors, Metabotropic Glutamate - drug effects
Receptors, N-Methyl-D-Aspartate - drug effects
title Interaction between metabotropic and NMDA glutamate receptors in the periaqueductal grey pain modulatory system
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T22%3A41%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interaction%20between%20metabotropic%20and%20NMDA%20glutamate%20receptors%20in%20the%20periaqueductal%20grey%20pain%20modulatory%20system&rft.jtitle=Naunyn-Schmiedeberg's%20archives%20of%20pharmacology&rft.au=Berrino,%20L&rft.date=2001-11-01&rft.volume=364&rft.issue=5&rft.spage=437&rft.epage=443&rft.pages=437-443&rft.issn=0028-1298&rft.eissn=1432-1912&rft_id=info:doi/10.1007/s002100100477&rft_dat=%3Cpubmed_cross%3E11692227%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c289t-37c0edffe4ad0c0c26985e325941e793de368164b76362de5da98b15760c0d273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/11692227&rfr_iscdi=true